Keywords: Multiple Sclerosis, Neurodegeneration
Motivation: Microstructure-informed tractography methods face challenges in presence of focal lesions.
Goal(s): This study aims to apply an extension of Myelin Streamline Decomposition (MySD) which accounts for lesions to patients with multiple sclerosis (MS) enrolled in a completed phase 2 clinical trial (SYNERGY) with conventional DTI acquisitions.
Approach: We applied our novel approach to perform network analysis in SYNERGY’s secondary progressive (SP) and relapsing-remitting (RR) patients.
Results: Using MySD applied to patients with focal pathology, we showed that SPMS patients had increased alterations in myelin-weighted network properties compared to RRMS. Myelin-weighted networks also exhibited correlations with motor and cognitive impairment.
Impact: For the first time, we applied our novel connectomics approach explicitly designed to cope with focal pathology to MS patients in a clinical trial, demonstrating its sensitivity and adaptability to real-world clinical data.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords